miércoles, 18 de noviembre de 2026

Fasting-Mimicking Diet vs. Calorie Restriction: Which Works Better for Weight Loss?

https://www.news-medical.net/health/Fasting-Mimicking-Diet-vs-Calorie-Restriction-Which-Works-Better-for-Weight-Loss.aspx Brief fasting-like cycles and sustained calorie reduction affect overlapping biological pathways, raising questions about how timing, protein intake, and refeeding shape their effects. Chronic caloric restriction (CCR) involves a sustained reduction in daily energy intake while maintaining adequate nutrition, whereas the fasting-mimicking diet (FMD) imposes substantial, often temporary, calorie restriction while permitting limited nutrient intake. A commonly studied FMD uses five consecutive days of restriction each month, emphasizing plant-based foods that reproduce selected fasting-related metabolic effects without complete food deprivation. These approaches differ in the timing and intensity of energy restriction, dietary composition, and whether they include refeeding periods between FMD cycles.1,2,5 Periodic FMD cycles may activate adaptive metabolic and cellular responses, including reduced insulin-like growth factor 1 (IGF-1) signaling, ketogenesis, and cellular stress responses, whereas CCR restricts intake continuously, rather than in discrete cycles. Both approaches can influence nutrient-sensing pathways and metabolic risk factors, with the cumulative energy deficit dependent on intake throughout the intervention, including FMD refeeding periods. FMD may be more acceptable for some individuals. To date, neither better adherence nor metabolic superiority over CCR has been established. Human studies report improvements in body mass index (BMI), waist circumference, and metabolic risk factors, though heterogeneous designs and dropout rates limit conclusions about superiority over CCR. Evidence from other intermittent fasting schedules provides context; however, it cannot establish the comparative effects of FMD.1,2,3,4

What Health Benefits Can Silkworm Protein Powder Offer? Reviewing the Evidence

https://www.news-medical.net/health/What-Health-Benefits-Can-Silkworm-Protein-Powder-Offer-Reviewing-the-Evidence.aspx From silk production to protein supplements, silkworm pupae are drawing scientific attention for their nutritional composition and the biological activity of their peptides. Introduction & Sustainable Protein Context Entomophagy, the consumption of edible insects, includes the established use of silkworm (Bombyx mori) pupae as food in several Asian countries.1,4 The silkworm is an economically important lepidopteran insect best known for silk production. While silkworm pupae are sometimes discarded as waste or used in animal feed or manure, they also have a history of human consumption. Current research examines their use in protein-rich food ingredients, rather than treating them solely as a waste stream.1 Silk reeling leaves the silkworm pupa as a byproduct from which silkworm pupa protein (SPP) can be extracted, typically through alkali extraction and acid precipitation. Limitations of these methods include wastewater generation and changes in protein conformation that can affect emulsifying and foaming properties. Organic solvents may also be used separately, including for defatting; however, their use is distinct from alkali extraction and acid precipitation.1

Does Losing One Sense Make Other Senses Stronger?

https://www.news-medical.net/health/Does-Losing-One-Sense-Make-Other-Senses-Stronger.aspx What happens in the brain when sight or hearing fades, and why do some remaining sensory abilities become sharper? "Sensory compensation" describes neural and behavioral adaptations that support interaction with the environment after impairment of a primary sensory modality. Losing vision or hearing, for example, can improve performance on certain tasks that rely more on the remaining senses; however, these benefits vary by individual and task. Compensation is often incomplete, and sensory loss can continue to limit everyday functioning.1,2

Can microplastics get under your skin? What everyday exposure could mean for your health

https://www.news-medical.net/news/20261117/Can-microplastics-get-under-your-skin-What-everyday-exposure-could-mean-for-your-health.aspx From cosmetics and synthetic clothing to airborne pollution, researchers examine how everyday exposure to tiny plastic particles could affect the skin and whether certain populations face greater risks. The term microplastics was introduced in 2004, and since then, these particles have been detected in various parts of the body, including human blood, lung, and placental tissue. In a recent narrative review published in the American Journal of Clinical Dermatology, researchers examined existing evidence on how these particles reach the skin and whether they contribute to skin disease.

Personalized vaccines work, making them is the hard part The science behind personalized mRNA cancer vaccines is working. Building a different drug for every patient, at scale, is the real fight. Written byAndrea Corona

Personalized vaccines work, making them is the hard part The science behind personalized mRNA cancer vaccines is working. Building a different drug for every patient, at scale, is the real fight. Written byAndrea Corona https://www.drugdiscoverynews.com/personalized-vaccines-work-making-them-is-the-hard-part-17504?utm_campaign=DDN_Newsletter_Dose&utm_medium=email&_hsenc=p2ANqtz-_YKyHbNCHJSI9Ha9CKBzZEcjwWLivbWWFZ5weD7dOaOpqiUdRm6h5fvJV8tr3ahBWYPYTlehApHi0KOVXD_3BRiacQSw&_hsmi=449776666&utm_content=449776666&utm_source=hs_email

AI-based analysis offers new roadmap for precision oncology The new approach combined digital pathology with spatial proteomics to uncover the secrets of metastasis and personalized treatment options. Written byAllison Whitten, PhD

AI-based analysis offers new roadmap for precision oncology The new approach combined digital pathology with spatial proteomics to uncover the secrets of metastasis and personalized treatment options. Written byAllison Whitten, PhD https://www.drugdiscoverynews.com/ai-based-analysis-offers-new-roadmap-for-precision-oncology-17460?utm_campaign=DDN_Newsletter_Dose&utm_medium=email&_hsenc=p2ANqtz-8LIehaN3cuMKhf44TpuDaCIzGuw3LCMND0KegpmAAT284K8D3j5Pvo7CQMKvIPDKutXUaS8XSMkC4bvyU0MClaeq4EOQ&_hsmi=449776666&utm_content=449776666&utm_source=hs_email How and why a tumor metastasizes — when a seemingly similar tumor doesn’t — remains one of the biggest questions in cancer research. New research from György Marko-Varga’s lab at Lund University with Istvan Nemeth at the Szeged Clinical hospital, and Peter Horvath’s team at HUN-REN Biological Research Centre suggests a new way to chip away at this question with the help of AI combined with spatial proteomics to reveal the single-cell dynamics of different populations of cancer cells within the same tumor. Their approach offers a promising step up over traditional molecular analyses that view the entire tissue sample at once and miss the functional differences in how different cell types behave. In their case report of a young woman with metastasized melanoma, the researchers identified two spatially distinct tumor cell populations in the original tumor. One, PT1, was an aggressive melanoma subtype that likely drove metastasis into the lungs and eventually the brain. Their analysis also surfaced metabolic and kinase programs associated with the progression and treatment resistance, which suggested that targeted therapies may not work well for the patient, with metabolic inhibitors potentially offering greater gains for the patient. “These findings demonstrate the potential of patient-specific AI-imaging interfaced with proteomic tumor mapping to move beyond conventional pathology, reveal actionable vulnerabilities, and guide more precise combination treatment strategies for advanced melanoma,” Marko-Varga told DDN.

Unexpected approach could crack key cancer signaling pathway Cancer researchers have attempted to target the WNT pathway for decades without success due to severe toxicity issues. A new paper could solve that problem. Written byAllison Whitten, PhD

https://www.drugdiscoverynews.com/unexpected-approach-could-crack-key-cancer-signaling-pathway-17660 For decades, targeting the WNT signaling pathway in cancer has eluded drug developers. That’s because while it’s a crucial pathway that drives uncontrolled cell division and tumor growth, it’s also essential in maintaining homeostasis in normal healthy tissues. Thus, any therapeutic that targets WNT and harms cancer cells also harms healthy cells, leading to severe toxicity and intolerable side effects in preclinical models. For example, a common strategy has been to target a pair of enzymes that regulate the WNT pathway, TNKS1 and TNKS2. But earlier work with dual inhibitors led to gastrointestinal damage in animal models. Now, Lukas Dow’s lab at Weill Cornell Medicine may have found a surprising way around these harsh side effects. His lab first built genetic tools to silence TNKS1 and TNKS2 independently of each other rather than silencing both. “When we started using them in cancer cell lines we noticed something unexpected: In some cases, suppressing TNKS2 alone was sufficient to suppress WNT,” Dow told DDN. In a new paper published in Nature Chemical Biology, Dow’s team generated a first-in-class TNKS2 inhibitor and showed that it successfully inhibited WNT signaling in TNKS1-deficient cell and organoid models.